Industry reports
Editor highlights

Cancer Therapy Research Reports, April 2014

You might be interested in: cancer, medical equipment, therapeutics, more »


 

1-10 of 16 reports for Cancer Therapy
Merger & Acquisition in Pharmaceuticals & Healthcare Industry: Stem Cell Therapeutics Corp. (SSS)

Merger & Acquisition in Pharmaceuticals & Healthcare Industry: Stem Cell Therapeutics Corp. (SSS)

  • $ 250
  • Industry report
  • February 2014
  • by Global Data

... The company discovers and devlops cancer stem cells and cancer therapies. Its products under clinical development include tigecycline, sirpafc, cd200 mab, tti-1612, and ntx-428. Sct's tigecycline ...

California Stem Cell, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

California Stem Cell, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • January 2014
  • by Global Data

... A number of neuromuscular disorders, including spinal muscular atrophy and amyotrophic lateral sclerosis. The company conducts phase ii clinical trials of cancer therapy for the treatment of metastatic ...

The 2013 Report on Cancer Therapy Pharmaceuticals: World Market Segmentation by City

The 2013 Report on Cancer Therapy Pharmaceuticals: World Market Segmentation by City

  • $ 795
  • Industry report
  • January 2013
  • by ICON Group

... Of the worldwide economic demand for launch vehicles to both regions and cities. This report takes the broader definition and considers, therefore, a city as a part of the global market. The 2013 report on cancer ...

The 2013-2018 Outlook for Cancer Therapy Pharmaceuticals in Japan

The 2013-2018 Outlook for Cancer Therapy Pharmaceuticals in Japan

  • $ 495
  • Industry report
  • January 2013
  • by ICON Group

... And/or sales force strategies. Using econometric models which project fundamental economic dynamics within each prefecture and city, latent demand estimates are created for cancer therapy ...

The 2013-2018 Outlook for Cancer Therapy Pharmaceuticals in the United States

The 2013-2018 Outlook for Cancer Therapy Pharmaceuticals in the United States

  • $ 495
  • Industry report
  • January 2013
  • by ICON Group

... Useful to distribution and/or sales force strategies. Using econometric models which project fundamental economic dynamics within each state and city, latent demand estimates are created for cancer therapy ...

The 2013-2018 World Outlook for Cancer Therapy Pharmaceuticals

The 2013-2018 World Outlook for Cancer Therapy Pharmaceuticals

  • $ 795
  • Industry report
  • January 2013
  • by ICON Group

... The 2013-2018 world outlook for cancer therapy pharmaceuticals this econometric study covers the world outlook for cancer therapy pharmaceuticals across more than 200 countries. For each year ...

Small-Molecule Targeted Cancer Therapies: World Market 2013-2023

Small-Molecule Targeted Cancer Therapies: World Market 2013-2023

  • $ 2 621
  • Industry report
  • December 2012
  • by Visiongain

... Multiple myeloma incidence will increase due to obesity8.4 Interview with dr kent c. Osborne, baylor college of medicine8.4.1 On challenges in developing anti-cancer therapies8 ...

Breast Cancer Therapies Markets

Breast Cancer Therapies Markets

  • $ 3 400
  • Industry report
  • November 2012
  • by TriMark Publications

... Breast cancer therapies markets breast cancer therapies are entering a new era as game-changers emerge for each of the major breast cancer patient populations. New market entrants must possess drug ...

MC - Mayo Clinic Phoenix Proton Cancer Therapy Center - Arizona - Construction Project Profile

MC - Mayo Clinic Phoenix Proton Cancer Therapy Center - Arizona - Construction Project Profile

  • $ 75
  • Industry report
  • October 2012
  • by World Market Intelligence Ltd

... As well as information on contracts, tendering and key project contacts.The mc - mayo clinic phoenix proton cancer therapy center - arizona - construction project profile is part of world market ...

Market and Product Forecasts: Top 20 Oncology Therapy Brands 2011-21 - Avastin fails to top any individual market in 2011

Market and Product Forecasts: Top 20 Oncology Therapy Brands 2011-21 - Avastin fails to top any individual market in 2011

  • $ 11 400
  • Industry report
  • September 2012
  • by Datamonitor

... Experienced by the key companies in the cancer therapy market makes the market extremely attractive to drug developers. Treatment of cancer has shifted toward a more focused attack on the disease with targeted ...


ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.